UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus

Cell, 2018-07, Vol.174 (3), p.576-589.e18

2018

Volltextzugriff (PDF)

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Nature genetics, 2014-02, Vol.46 (2), p.126-135

2014

Volltextzugriff (PDF)

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

World journal of surgical oncology, 2021-06, Vol.19 (1), p.1-190, Article 190

2021

Volltextzugriff (PDF)

CIP2A expression is increased in prostate cancer

Journal of experimental & clinical cancer research, 2010-10, Vol.29 (1), p.136-136, Article 136

2010

Volltextzugriff (PDF)

Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer

International journal of surgical oncology, 2021, Vol.2021, p.1-7

2021

Volltextzugriff (PDF)

Treatment of renal angiomyolipoma: pooled analysis of individual patient data

BMC urology, 2015-12, Vol.15 (117), p.123-123, Article 123

2015

Volltextzugriff (PDF)

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial

European urology, 2016-03, Vol.69 (3), p.419-425

2016

Volltextzugriff (PDF)

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

Journal of experimental & clinical cancer research, 2011-09, Vol.30 (1), p.84-84, Article 84

2011

Volltextzugriff (PDF)

The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study

Scandinavian journal of surgery, 2024-09, Vol.113 (3), p.219-228

2024

Volltextzugriff (PDF)

Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer

BJU international, 2019-12, Vol.124 (6), p.992-998

2019

Volltextzugriff (PDF)

Urinary Sample Collection Methods in Ileal Conduit Urinary Diversion Patients: A Randomized Control Trial

Journal of wound, ostomy, and continence nursing, 2018-01, Vol.45 (1), p.59-62

Vaarala, Markku H.

2018

Volltextzugriff (PDF)

Evaluation of neuroendocrine markers in renal cell carcinoma

Diagnostic pathology, 2010-05, Vol.5 (1), p.28-28, Article 28

2010

Volltextzugriff (PDF)

The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer

International journal of cancer, 2008-06, Vol.122 (11), p.2511-2516

2008

Volltextzugriff (PDF)

Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues

The Journal of pathology, 2001-01, Vol.193 (1), p.134-140

2001

Volltextzugriff (PDF)

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

Journal of experimental & clinical cancer research, 2010-01, Vol.29 (1), p.2-2, Article 2

2010

Volltextzugriff (PDF)

Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression

Laboratory investigation, 2000-08, Vol.80 (8), p.1259-1268

2000

Volltextzugriff (PDF)

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

Acta oncologica, 2023-08, Vol.ahead-of-print (ahead-of-print), p.1-7

2023

Volltextzugriff (PDF)

Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology

Scandinavian journal of urology, 2018-03, Vol.52 (2), p.111-115

2018

Volltextzugriff (PDF)

DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer

Radiotherapy and oncology, 2014-08, Vol.112 (2), p.233-236

2014

Volltextzugriff (PDF)

Identification of androgen-regulated genes in human prostate

Molecular medicine reports, 2012-09, Vol.6 (3), p.466-472

2012

Volltextzugriff (PDF)

HuR expression is a marker of poor prognosis in renal cell carcinoma

Tumor biology, 2011-06, Vol.32 (3), p.481-487

2011

Volltextzugriff (PDF)

Tumor infiltrating CD8+ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma

Oncoimmunology, 2015-06, Vol.4 (6), p.e1002726-e1002726

2015

Volltextzugriff (PDF)

External beam radiation for the treatment of castration-resistant prostate cancer following primary hormonal therapy with androgen ablation: Analysis and outcome of 21 patients

Molecular and clinical oncology, 2017-03, Vol.6 (3), p.428-432

2017

Volltextzugriff (PDF)

8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma

International journal of clinical and experimental pathology, 2011-03, Vol.4 (3), p.267-275

2011

Volltextzugriff (PDF)

Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostate cancer

Molecular and clinical oncology, 2016-11, Vol.5 (5), p.647-650

2016

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding

Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status—results from a Finnish nation-wide population-based study from 2005 to 2010

CIP2A expression is increased in prostate cancer

Transition to Targeted Therapies Improved the Prognosis and Increased the Utilization of Medical Treatments among Patients with Synchronous Metastatic Renal Cell Cancer

Treatment of renal angiomyolipoma: pooled analysis of individual patient data

Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial

Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study

Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer

Urinary Sample Collection Methods in Ileal Conduit Urinary Diversion Patients: A Randomized Control Trial

Evaluation of neuroendocrine markers in renal cell carcinoma

The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer

Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues

Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma

Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer Progression

Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

Lesion size on prostate magnetic resonance imaging predicts adverse radical prostatectomy pathology

DuraSeal® as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer

Identification of androgen-regulated genes in human prostate

HuR expression is a marker of poor prognosis in renal cell carcinoma

Tumor infiltrating CD8+ T lymphocyte count is independent of tumor TLR9 status in treatment naïve triple negative breast cancer and renal cell carcinoma

External beam radiation for the treatment of castration-resistant prostate cancer following primary hormonal therapy with androgen ablation: Analysis and outcome of 21 patients

8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma

Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostate cancer

Suchergebnisse filtern